Souders Financial Advisors Akebia Therapeutics, Inc. Transaction History

Souders Financial Advisors

  • $610 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$2.39 - $13.08 $111,448 - $609,933
-46,631 Closed
0 $0
Q2 2020

Aug 11, 2020
SELL
$6.67 - $13.58 $79,399 - $161,656
-11,904 Reduced 20.34%
46,631 $633,000
Q1 2020

May 12, 2020
BUY
$4.1 - $10.24 $239,993 - $599,398
58,535 New
58,535 $444,000

Others Institutions Holding AKBA

# of Institutions
127
Shares Held
56.7M
Call Options Held
937K
Put Options Held
743K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $173M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Souders Financial Advisors Portfolio

Follow Souders Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email